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Summary
 
Genes were isolated using the suppression subtractive hybridization method by stimulation of
pro/pre B cells with anti-CD40 and interleukin (IL)-4 to mature S
 
m
 
-S
 
e
 
–switched cells. One of
the strongly upregulated genes encodes a novel murine CC chemokine we have named
ABCD-1. The ABCD-1 gene has three exons separated by 1.2- and 2.7-kb introns. It gives
rise to a 2.2-kb transcript containing an open reading frame of 276 nucleotides. Two polyade-
nylation sites are used, giving rise to cDNAs with either 1550 or 1850 bp of 3
 
9
 
 untranslated re-
gions. The open reading frame encodes a 24 amino acid–long leader peptide and a 68 amino
acid–long mature protein with a predicted molecular mass of 7.8 kD. ABCD-1 mRNA is
found in highest quantities in activated splenic B lymphocytes and dendritic cells. Little
chemokine mRNA is present in lung, in unstimulated splenic cells, in thymocytes, and in
lymph node cells. No ABCD-1 mRNA is detected in bone marrow, liver, kidney, or brain, in
peritoneal exudate cells as well as in the majority of all unstimulated B lineage cells tested. It is
also undetectable in Concanavalin A–activated/IL-2–restimulated splenic T cells, and in bone
marrow–derived IL-2–induced natural killer cells and IL-3–activated macrophages. Recombi-
nant ABCD-1 revealed a concentration-dependent and specific migration of activated splenic
T lymphoblasts in chemotaxis assays. FACS
 
Ò
 
 analyses of migrated cells showed no preferential
difference in migration of CD4
 
1
 
 versus CD8
 
1
 
 
 
T cell blasts. Murine as well as human T cells re-
sponded to ABCD-1. Freshly isolated cells from bone marrow, thymus, spleen, and lymph
node, IL-2–activated NK cells, and LPS-stimulated splenic cells, all did not show any chemo-
tactic response. Thus, ABCD-1 is the first chemokine produced in large amounts by activated
B cells and acting selectively on activated T lymphocytes. Therefore, ABCD-1 is expected to
play an important role in the collaboration of dendritic cells and B lymphocytes with T cells in
immune responses.
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W
 
hen a T cell–dependent humoral immune response
is initiated in a secondary lymphoid organ like the
spleen, T and B cells get near to each other in areas which
are rich in interdigitating dendritic cells (DC)
 
1
 
 capable of
presenting antigen (1–4). While the majority of the clonally
expanded B cells initially differentiate into IgM-producing
plasma cells, a small number of them migrate into those ar-
eas of the spleen in which follicular dendritic cells (FDC)
 
tion, normal T cell expressed and secreted; RT, reverse transcription;
STCP-1, stimulated T cell chemotactic protein 1; TARC, thymus and
activation–regulated chemokine.
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Abbreviations used in this paper:
 
 BCA-1, B cell–attracting chemokine 1; BLC,
B lymphocyte chemoattractant; BLR, Burkitt’s lymphoma receptor; DC,
dendritic cell(s); FDC, follicular dendritic cell(s); FPLC, fast-performance
liquid chromatography; MCP, monocyte chemotactic protein; MDC,
macrophage-derived chemokine; MIP, macrophage-inflammatory protein;
RAG, recombination activating gene; RANTES, regulated upon activa-
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are localized. There they proliferate, hypermutate the vari-
able (V)-region portions of their Ig H- and L-chain genes,
and initiate Ig H-chain class switching. The extensive pro-
liferation of B cells and their maturation lead to the forma-
tion of germinal centers at the sites of the follicles.
Th cells are essential for the generation of germinal centers,
for somatic hypermutation of Ig genes, for Ig H-chain class
switching, and for memory B cell formation (2, 5–9). One of
the mandatory interactions leading to a germinal center reac-
tion is that of the CD40 ligand on Th cells with CD40 on B
cells (10, 11). The stimulatory strength of this interaction can
be seen in tissue culture, when either soluble CD40 ligand or
CD40-specific mAbs activate B cells to polyclonal prolifera-
tion and Ig secretion (for a review, see reference 12). When
IL-4 is added, switching to IgG1 and IgE production can be
observed (for a review, see reference 13). Such anti-CD40
plus IL-4–induced S
 
m
 
-S
 
e
 
 switching can even be observed in
vitro in half or more of the differentiated pro B cells from
recombination activating gene (RAG)-2
 
2
 
/
 
2
 
 
 
mice (14). Since
these pro B cells can be expanded to large numbers by growth
on stromal cells in the presence of IL-7 (15), they—and their
differentiated, S
 
m
 
-S
 
e
 
–switched counterparts—appeared ideal
to construct cDNA libraries. The subtraction of genes ex-
pressed in the pro B cells from those expressed in the differen-
tiated, S
 
m
 
-S
 
e
 
–switched cells might lead to the isolation of
genes involved in germinal center formation, somatic hyper-
mutation, Ig class switching, and memory formation. This has
been attempted in this paper.
Only limited information exists concerning the molecu-
lar mechanisms that regulate the selective migration of T
and B cells into the areas of a follicle, and their residence at
the sites where interactions between T and B cells can take
place which generate a germinal center. It is evident that
chemokines and their receptors play an important role in
the collaboration of T and B cells and in the formation of a
germinal center
 
 
 
(16).
Chemokines comprise a group of secreted proteins
whose best described biological function is to selectively
control the migration of certain leukocyte populations to
localized sites of inflammatory or immune reactions (16–
19). Chemokines have been classified in four families based
on the relative position of their first two of four critical and
conserved cysteine residues. In the CXC or 
 
a
 
 family, the
two NH
 
2
 
-terminal cysteine residues are separated by one
amino acid; in the CC or 
 
b
 
 family, they are adjacent; in the
C or 
 
g
 
 family, only one of the two cysteine residues is con-
served (20); and finally, in the CX3C family, the cysteine
residues are separated by three amino acids (21). Chemo-
kines act on all different types of cellular targets; however, the
CC chemokines tend to act usually on monocytes, T lym-
phocytes, and in some cases eosinophils, basophils, and mast
cells. The repertoire of CC chemokines has expanded rapidly
to include macrophage-inflammatory protein (MIP)-1
 
a
 
,
-1
 
b
 
, -3
 
a
 
,
 
 also reported as exodus or liver and activation–
regulated chemokine (LARC), and -3
 
b
 
 or EBV-induced
molecule 1–ligand chemokine (ELC), RANTES (regulated
upon activation, normal T cell expressed and secreted), I-309,
monocyte chemotactic protein (MCP)-1, -2, -3, and -4, eo-
 
taxin, thymus and activation–regulated chemokine (TARC),
B lymphocyte chemoattractant (BLC), also reported as B cell–
attracting chemokine (BCA)-1 in humans, and DC-CK-1.
These molecules are usually 70–100 amino acids long and
have 25–70% homology to each other. They act through G
protein–coupled seven transmembrane domain receptors (22).
FDC are suspected to be the source of BLC/BCA-1, a
chemokine recognized on B cells by the Burkitt’s lym-
phoma receptor (BLR)-1/CXCR5 chemokine receptor
(23, 24). BLC/BCA-1 attracts B cells into the follicles, a
process that becomes defective in BLR-1
 
2
 
/
 
2
 
 mice (16).
Antigen-pulsed DC produce DC-CK-1, which attracts na-
ive T cells to be activated near T cell–rich zones of the
spleen (25). This, in turn, sets the stage for activated T cells
to be attracted into the follicles for collaboration with B cells.
One of the highly expressed genes identified in the sub-
traction library encodes a novel CC chemokine. This
chemokine, named ABCD-1 by us, is expressed by acti-
vated B cells and DC, and attracts activated T cells. This
study describes the isolation and structural characterization
of the gene, its expression pattern, and the chemoattractive
targets of its protein. It discusses the possible function of
this novel chemokine within a T cell–dependent humoral
response of B cells.
 
Materials and Methods
 
Mice and Cells.
 
C57Bl/6 mice or RAG-2–deficient mice,
originally obtained from F. Alt (Children’s Hospital, Boston,
MA), were maintained at the animal facilities of the Basel Insti-
tute for Immunology and Umeå University. RAG-2–deficient,
bcl-2 transgenic pro B cells (R2BFL) and the normal, bcl-2 trans-
genic fetal liver pre B cell line (bcl-2-5.8) were established, main-
tained in culture, and induced to differentiate by anti-CD40 mAb
plus IL-4 as described previously (14, 15, 26).
The B lineage cell lines 63-12 (27), 38B9 (28, 29), NFS-5 (30),
70Z/3 (31), A20 (32), WEHI-231 (33), J558 (34), X63 (35), and
Sp2/0 (36), the T lineage cell lines BW5147 (37, 38) and EL-4
(38), ST-2 stromal cells (39), and ex vivo cells were cultured in
IMDM (GIBCO BRL, Gaithersburg, MD) containing 5 
 
3
 
 10
 
2
 
5
 
 M
2-ME, 1
 
3
 
 nonessential amino acids (GIBCO BRL), 0.03% pri-
matone (Quest International, Naarden, The Netherlands), 100
 
m
 
g/ml kanamycin (GIBCO BRL) (complete medium), 2% FCS
(BioConcept, Allschwil, Switzerland). The cytotoxic T cell line
CTLL (40) was grown in complete medium, 2% FCS, and 10
 
3
 
U/ml recombinant (r)IL-2. All cytokines used in this study were
obtained from an X63 cell line transfected with the appropriate
cytokine cDNA
 
 
 
(41).
For stimulation, cells were washed three times and cultured in
complete medium, 2% FCS, and different stimuli. Anti-CD40
mAb
 
 
 
(14) was used at 10 
 
m
 
g/ml; rIL-4 at 100 U/ml; 
 
Escherichia
coli
 
 LPS (a gift from Drs. C. Galanos and O. Luderitz, Max-
Planck-Institut, Freiburg, Germany) at 10 
 
m
 
g/ml; and anti-
 
m
 
(clone M41 [42]) coupled to Sepharose beads at 200 
 
m
 
g/ml.
T lymphoblasts were obtained by culturing splenic cells in
complete medium, 10% FCS in the presence of 2.5 
 
m
 
g/ml Con
A (Sigma Chemical Co., St. Louis, MO) for 2 d. To remove Con
A, cells were incubated on ice for 30 min with 50 mM methyl-
 
a
 
-
 
d
 
-mannopyranoside (Sigma Chemical Co.) and washed once
with complete medium, 2% FCS. Cells were restimulated with
10
 
3
 
 U/ml rIL-2 for 1 or 2 d. The population obtained after 2-d 
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culture in the presence of rIL-2 was 43% CD4
 
1
 
 single positive,
50% CD8
 
1
 
 single positive, and 7% CD4
 
2
 
CD8
 
2
 
 double negative
(data not shown).
NK cells were obtained by growing RAG-2–deficient bone
marrow cells in complete medium, 2% FCS, and 10
 
3
 
 U/ml rIL-2
as described previously (43). After 6 d of culture, proliferating
cells were granulous and had the phenotype of NK1.1
 
1
 
, IL-2R
 
a
 
2
 
,
IL-2R
 
b
 
1
 
 NK cells (reference 43, and data not shown). At this
time point, the cells were harvested and used for RNA isolation
or for chemotaxis assays.
Macrophages were obtained by culture of RAG-2–deficient
bone marrow cells in complete medium, 2% FCS in the presence
of 10
 
3
 
 U/ml rIL-3. At the end of the 6-d culture period, the cells
that adhered to the plastic culture dish and showed morphology
of macrophages were harvested, RNA was extracted, and cDNA
was prepared.
Mesenteric LN CD11c
 
1
 
 
 
DC were purified as described else-
where (44). Maturation was induced in vitro by culture of the
cells for 24 h in the presence of 10 
 
m
 
g/ml anti-CD40 mAb or 20
ng/ml GM-CSF and 50 ng/ml TNF-
 
a
 
. Cells were then har-
vested, total RNA was isolated, and cDNA was prepared.
Human neonatal leukocytes were isolated from cord blood by
the standard Ficoll-Paque method. CD4-enriched T cells were
obtained by negative sorting with anti-CD8 mAb (clone OKT8),
and stimulated with plate-bound anti-CD3 mAb (clone TR66, 5
 
m
 
g/ml [45]) and anti-CD28 mAb (clone CD28.6, 2 
 
m
 
g/ml; pro-
vided by D. Olive, INSERM, Marseille, France) and either with
human rIL-12 (2 ng/ml; Hoffmann-La Roche, Nutley, NJ) plus
neutralizing mAb to IL-4 (200 ng/ml; PharMingen, San Diego,
CA) or with human rIL-4 (200 U/ml; PharMingen) plus neutral-
izing mAb to human IL-12 (2 
 
m
 
g/ml; R&D Systems, Inc., Min-
neapolis, MN) in RPMI 1640 medium supplemented with 2 mM
 
l
 
-glutamine, 1% nonessential amino acids, 1% pyruvate, 5 
 
3
 
 10
 
2
 
5
 
 M
2-ME, 50 
 
m
 
g/ml kanamycin, and 5% human serum (Swiss Red
Cross, Bern, Switzerland). Human rIL-2 (500 U/ml) was added
at day 3. After 1 wk, the cultures were restimulated in the same
polarizing conditions and analyzed after 10 d of culture.
 
Chemotaxis Assay.
 
Cell migration was evaluated using 5-
 
m
 
m
pore filters (Transwell, 24-well cell cluster; Costar Corp., Cam-
bridge, MA). Cells were washed once, adjusted to 3 
 
3
 
 10
 
6
 
 cells/ml,
and incubated in complete medium, 2% FCS for 10–15 min at
37
 
8
 
C in 10% CO
 
2
 
. 5 
 
3
 
 10
 
5
 
 cells were placed onto the Transwell
filter which had been preincubated with complete medium, for
10 min. Filters were then transferred to another well containing
500 
 
m
 
l of complete medium and different concentrations of
ABCD-1 purified either by immunoaffinity or HighTrap Hep-
arin fast-performance liquid chromatography (FPLC; Pharmacia
Biotech AB, Uppsala, Sweden), and incubated at 37
 
8
 
C in 10%
CO
 
2
 
. After 3 h, the upper chamber was removed, and the cells in
the lower chamber were counted using a Neubauer hemocytom-
eter. The phenotype of the migrated cells was determined by
FACS
 
Ò
 
 analysis. Results are expressed as percentage of migrated
cells to total cells used in the assay.
 
Selection of cDNAs.
 
Total RNA of in vitro–stimulated cells
was isolated with the RNAeasy system (QIAGEN GmbH,
Hilden, Germany), and poly-A
 
1
 
 mRNA was selected using the
Qiaex system according to the instructions of the manufacturer
(QIAGEN GmbH). The quality of the isolated RNA was evalu-
ated by Northern blot analysis using formaldehyde gels.
Suppression subtractive hybridization was performed using the
PCR-Select kit (Clontech, Palo Alto, CA) essentially as described
by Diatchenko et al. (see reference 50). In brief, complementary
DNA was synthesized from 4 
 
m
 
g of mRNA either from R2BFL
 
cells growing on stromal cells in the presence of IL-7, or from
R2BFL cells stimulated with anti-CD40 mAb plus IL-4 in the
absence of IL-7. The cDNAs were digested with RsaI, and two
types of adapters, provided by the manufacturer, were indepen-
dently ligated. First and second hybridizations were performed,
and the resulting annealed material was used as PCR template.
Routinely, 2 
 
m
 
l of 1:1,000, 1:300, 1:100, and 1:30 diluted hy-
bridization mixture was amplified in 30 primary PCR cycles,
with the primers provided by the manufacturer. 15–17 cycles of
secondary PCR were done using 2 
 
m
 
l of 1:20, 1:10, and 1:5 di-
luted primary PCR as template. PCR reactions were performed
with the Advantage PCR system (Clontech). PCR products were
ligated in the pT7Blue vector (Novagen, Inc., Madison, WI), and
sublibraries of potentially subtracted cDNAs were established.
This led to the establishment of 
 
z
 
500 cDNA clones. 120 ran-
domly chosen clones were sequenced.
 
Sequencing Analyses.
 
The nucleotide sequence of the isolated
cDNA clones was determined using the dye terminator cycle se-
quencing kit (Perkin-Elmer Corp., Foster City, CA) and running
the samples in an automatic sequencer (Applied Biosystems Inc.,
Foster City, CA), or using super coiled plasmids and conventional
sequencing protocols (46). The sequences were analyzed using
Genetics Computer Group software (Madison, WI) and search
launcher software available on the Internet (National Center for
Biotechnical Information, http://www.ncbi.nlm.nih.gov). Expres-
sion of potentially interesting cDNA clones was studied in
Northern blot analyses and/or by semiquantitative reverse tran-
scription (RT)-PCR using specific primers.
 
Semiquantitative RT-PCR and Northern Blotting.
 
Total RNA
was extracted using RNAzol B (Biotecx Laboratories, Inc.,
Houston, TX) according to the manufacturer’s instructions.
Maximally 1 
 
m
 
g of total RNA was reverse transcribed for 1 h at
37
 
8
 
C. The RT mix contained 50 mM Tris (pH 8.3), 3 mM
MgCl
 
2
 
, 75 mM KCl, 10 mM dithiothreitol, 1 mM each dATP,
dGTP, dCTP, and dTTP (Pharmacia Biotech AB), 0.2 U pd(N)
 
6
 
sodium salt (Pharmacia Biotech AB), 40 U RNAse Block Ribo-
nuclease Inhibitor (Stratagene Inc., La Jolla, CA), and 50 U
M-MLV reverse transcriptase (GIBCO BRL). The PCR mix
consisted of 10 mM Tris (pH 8.3), 1.5 mM MgCl
 
2
 
, 50 mM
KCl, 10 mM 2-ME, 0.01% gelatin, 0.2 mM each dATP, dGTP,
dCTP, and dTTP (Pharmacia Biotech AB), and 0.5 U Amplitaq
DNA polymerase (Roche Diagnostics Systems, Basel, Switzer-
land).
Primers used for PCR were 5
 
9
 
 and 3
 
9
 
 ABCD-1 (5
 
9-GCCCTC-
TGGTCATTAGACACCTG-39 and 59-TCGTTGGCAAGG-
CTCTTGCTG-39), resulting in a 413-bp fragment; 59 and 39
RANTES (59-TCTGCAGCTGCCCTCACCATCATC-39 and
59-TGCCCATTTTCCCAGGACCGAGTG-39), amplifying a
335-bp product; 59 and 39 MIP-1a (59-ATCATGAAGGTCTCC-
ACCAC-39 and 59-TCTCAGGCAATCAGTTCCAG-39), giving
rise to a 284-bp fragment; 59 and 39 MCP-1 (59-AAGCCAGCT-
CTCTCTTCCTC-39  and 59-CCTCTCTCTTGAGCTTG-
GTG-39), resulting in a 247-bp product; and 59 and 39 MDC/
STCP-1 (59-CTGCACTCCTGGTTGTCCTC-39 and 59-ACG-
GTCATCAGAGTAGGCTC-39), producing a 297-bp fragment.
PCR was performed on a thermal cycler (OmniGene; Hybaid
Ltd., Hampton Hill, Middlesex, UK). Serially diluted cDNA (1:5
serial dilutions) was amplified by PCR using the following condi-
tions: 35 cycles of 30 s at 948C, 20 s at 588C, and 30 s at 728C fol-
lowed by 45 s at 948C, 90 s at 588C, and 2 min at 728C. Parallel
PCR reactions were set using primers specific for b-actin in the
mouse studies, 59 and 39 b-actin (59-GTGGGAATTCGTCA-
GAAGGACTCCTATGTG-39 and 59-GAAGTCTAGAGCAA-454 B and Dendritic Cells Produce T Cell–directed CC Chemokine
CATAGCACAGCTTCTC-39), amplifying a 537-bp product;
and G3PDH in the human studies, 59 and 39 G3PDH (59-ACC-
ACAGTCCATGCCATCAC-39  and 59-TCCACCACCCT-
GTTGCTGTA-39), amplifying a 451-bp product, to normalize
for possible differences in the amount of cDNA synthesized.
PCR products were separated in 1.2% TAE-agarose gels. The
amount of specific mRNA relative to b-actin in the mouse or to
G3PDH in the human cDNA, respectively, was estimated in se-
rial 1:5 dilutions of the cDNA analyzed on gels stained with
ethidium bromide. The results of this semiquantitative RT-PCR
analysis are expressed in Results as relative quantities.
The probe encoding ABCD-1 sequences used for Northern
hybridization was a 457-bp fragment containing bases 10–466 of
the ABCD-1 cDNA (Fig. 1) labeled with [a-32P]dCTP (Amer-
sham International, Little Chalfont, Bucks, UK) by random prim-
ing, using the NEBlot kit (New England Biolabs, Inc., Beverly,
MA). Approximately 30 mg of total RNA of tissues or 4 mg of
nonstimulated or anti-CD40 plus IL-4–induced R2BFL cells was
fractionated on a 1.5% agarose formaldehyde gel, transferred to
GeneScreen-plus nylon membrane (DuPont-NEN, Boston,
MA), prehybridized for 4 h at 658C in 0.5 M Na2HPO4/
NaH2PO4 (pH 7.2), 7% SDS, 1 mM EDTA, and hybridized
overnight in the same solution with labeled probe. Membranes
were washed twice with 40 mM Na2HPO4/NaH2PO4 (pH 7.2),
1% SDS for 30 min at 658C. Autoradiographs were exposed at
2708C for 6 h for ABCD-1, or for 2 h for b-actin.
Full-length cDNA Clones. A cDNA library was constructed
using total RNA from stimulated R2BFL cells. Complementary
DNA was synthesized with the PCR-based system CAP-finder
(Clontech) according to the instructions of the manufacturer and
was then subcloned into a l-ZAP Express vector (Stratagene
Inc.). Ligated cDNAs were packaged into l-phages using Giga-
pack III Gold packaging extracts (Stratagene Inc.). The library
was screened using the D2-2 cDNA fragment, which was shown
to contain coding sequences of ABCD-1.
Isolation of Genomic Clones. To obtain ABCD-1 genomic
DNA clones, the 129SVJ mouse genomic library (Stratagene Inc.)
was screened using a full-length cDNA according to the instruc-
tions of the manufacturer. Positive phage clones were isolated and
mapped as described previously (47).
Production of Recombinant ABCD-1. A 457-bp fragment con-
taining the complete coding region of the ABCD-1 cDNA clone
(Fig. 1, bases 10–466) was cloned into the BamHI-SalI site of the
expression vector pRmHa-3 (48). 3 mg of plasmid together with
0.3 mg of pBS-hs.PURO plasmid (K. Karjalainen, unpublished
data) were cotransfected into SL-3 cells (49). In brief, the two
plasmids were dissolved in 100 ml SF 900 II SF medium (GIBCO
BRL) supplemented with 0.35 g/liter NaHCO3 (complete insect
medium), and then incubated with 100 ml complete insect me-
dium and 10 ml lipofectin (GIBCO BRL) at room temperature
for 10 min. 90% confluent layer of SL-3 cells in 1.8 ml complete
insect medium was incubated with the 200 ml plasmids/lipofectin
mixture at 278C for 5 h. The medium was then carefully re-
moved and exchanged for 5 ml complete insect medium, 1% FCS
(GIBCO BRL). 2 d later, cells were subjected to selection pres-
sure in complete insect medium, 1% FCS, and 10 mg/ml puro-
mycin (Calbiochem Corp., La Jolla, CA). ABCD-1 expression
was induced in the transfected SL-3 cells by the addition of 1 mM
CuSO4. 4 d later, cells were checked for ABCD-1 expression by
RT-PCR using the primer pair FCC1 (59-CTGGGATCCAT-
GTCTGCTTGGTAGTGA-39) and UCC1 (59-CATGTCGAC-
GAAGAATAGGGCTTGCTG-39), and the conditions described
above. Positive cell clones were expanded in complete insect me-
dium, 0.2–1% FCS, and 10 mg/ml puromycin. ABCD-1 was iso-
lated from 5-d–induced culture supernatant by passage through a
0.45-mm pore filter and over a HighTrap Heparin FPLC column
(Pharmacia Biotech AB) at 0.5 ml/min. The column was washed
with 20 mM Tris (pH 8), 200 mM NaCl and eluted with a linear
gradient of 20 mM Tris (pH 8) and increasing 20 mM/min NaCl.
Alternatively, ABCD-1 was purified from induced culture su-
pernatant by immunoaffinity using ABCD-1 mAb (see below
for production of specific mAb) coupled to CNBr-activated
Sepharose (Pharmacia Biotech AB) according to the manufac-
turer’s instructions. Eluted fractions were checked for ABCD-1
by ELISA and fractionated on an 18% acrylamide SDS-PAGE gel
using a Mini Trans-Blot Cell (Bio-Rad Laboratories, Hercules,
CA). The gel was either silver stained or electroblotted onto a nitro-
cellulose membrane followed by immunodetection of ABCD-1
by incubation with anti–ABCD-1 mAb (10 mg/ml) overnight
and ECL (Amersham International) detection, or onto a polyvi-
nylidene fluoride membrane (Bio-Rad Laboratories) for protein
sequencing. The fractionated 7.8-kD protein, transferred to poly-
vinylidene fluoride membrane, was NH2-terminally sequenced
on a protein sequencer (model 494; Applied Biosystems Inc.).
The predicted mature form of ABCD-1 was chemically syn-
thesized at the Basel Institute for Immunology using FastMocTM
Figure 1. Structure of ABCD-1 mRNA. The putative leader sequence
(double-underlined), the critical cysteine residues (bold), the potential
heparin binding site at the COOH terminus (underlined), and the two
polyadenylation sites that are used in ABCD-1–encoding cDNAs (bold
and underlined) are shown. Triangles, Positions where the coding regions
are split by introns. The cDNA sequence of ABCD-1 can be found in
EMBL/GenBank/DDBJ under accession no. AF052505.455 Schaniel et al.
chemistry on a peptide synthesizer (model 430A; Applied Biosys-
tems Inc.). Lyophilized protein was dissolved at 5 mg/ml in PBS
and stored at 2708C.
Production of ABCD-1 mAb. Lewis rats were immunized with
100 mg of synthetic ABCD-1 emulsified with CFAs. Rats were
boosted with 20 mg of chemically synthesized ABCD-1 after 5 wk
and then after an additional 3 d. 1 d thereafter, the animals were
killed, and the LN cells were fused with Sp2/0 myeloma cells,
according to standard protocol.
Results
Development of Subtracted Pools of cDNAs. We have used
the recently described suppression subtractive hybridization
method (50) to isolate genes preferentially expressed in
anti-CD40 plus IL-4–stimulated cells of the IL-7–depen-
dent pro B cell line R2BFL. This method combines nor-
malization of cDNA abundance and subtraction in a single
procedure. We have subtracted our cDNA populations as
described in Materials and Methods and amplified by
PCR-upregulated sequences. Southern blot analyses of the
selected PCR products using the G3PDH-specific probe
demonstrated a .1,000-fold elimination of sequences en-
coding this housekeeping gene (data not shown). The pool
of cDNA fragments potentially containing cDNA se-
quences selectively expressed in the anti-CD40 plus IL-4–
differentiated B lineage cells was subcloned into a cloning
vector. Screening the sequences of the first 120 clones con-
taining inserts .150 bp in the available databases revealed
that 23 of these 120 clones were encoding parts of genes that
are already known and could be expected to be upregulated
in anti-CD40 and IL-4–differentiated B lineage cells (14).
Hence, clones encoding the invariant chain of MHC class II
(51), MHC class II molecules (52), the MHC locus gene
H2-M (53), several Ig germline transcripts associated with Ig
class switching (for a review, see reference 54), CD23 (55),
and the IL-4 receptor (56) were found (Table 1). These re-
sults were taken as evidence for a successful enrichment of
specific cDNA sequences in our subtracted sublibrary.
cDNA Clone D2-2 Encodes a Novel Murine Chemokine.
A high number of cDNA fragments (10/120), including
clone D2-2, showed the very same high homology to the
coding sequences of the chemokine RANTES (z59% ho-
mology at the nucleotide level in 167 bp, and 38% similar-
ity at the potentially encoded mature protein sequence
level [57–59]). This indicated that the gene(s) from which
these fragments were derived could encode one or several
novel chemokine(s). Using the D2-2 cDNA fragment, full-
length cDNA clones were isolated from a library con-
structed with mRNA from anti-CD40 plus IL-4–stimu-
lated R2BFL cells. Two types of cDNAs were deduced,
differing at their 39 ends. Sequencing analyses demonstrated
that this was due to differential usage of two polyadenyla-
tion sites separated from each other by z300 bases (Fig. 1).
The two cDNAs contained a single open reading frame en-
coding a 92 amino acid–long unprocessed secretory pep-
tide. The critical cysteine residues are organized in a pat-
tern characteristic for the CC or b chemokine subfamily.
We named this novel murine CC chemokine ABCD-1.
Using the cDNA clone as a probe, l-phage genomic
DNA clones were isolated that contained the entire ABCD-1
chemokine gene. Comparison of the cDNA and genomic
sequences revealed that like other CC chemokine genes,
Figure 2. (A) Schematic repre-
sentation of the mouse ABCD-1
genetic locus. Boxes, Exons: gray
boxes, 59 and 39 untranslated re-
gions; black boxes, coding regions.
Exon I contains the translation
start site; exon II contains the
critical CC residues; exon III
contains the stop codon and the
39 untranslated region. (B) Nu-
cleotide sequences of the splice
junctions and comparison with
the corresponding human se-
quences (derived from reference
62). Lower case letters, Intron se-
quences. Upper case letters, Exon
sequences.
Table 1. Gene Fragments Detected in B Lineage Cells Induced by 
CD40-specific mAb and IL-4
Gene
No. of independent
isolates (of 120 total)
Invariant chain MHC class II 7
Class II (a and b chains of I-A and I-E) 5
H2-M 2
Ig1 germline transcript 2
Ie germline transcript 4
CD23 1
IL-4 receptor 2
ABCD-1 10
Total 33456 B and Dendritic Cells Produce T Cell–directed CC Chemokine
three exons encoded the entire cDNA sequences (Fig. 2).
The exons are separated by introns of z1.2 and 2.7 kb,
respectively.
Knowledge of the complete sequence of the ABCD-1
chemokine gene also made it clear that all 10 cDNA clones
with close sequence homologies identified in the original
subtractive library originated from the same gene.
mRNA for the Novel ABCD-1 Chemokine Is Produced Pri-
marily by Activated B Cells and DC. The expression pat-
tern of ABCD-1 at the RNA level was studied by North-
ern blot hybridization (Fig. 3) and/or by semiquantitative
RT-PCR (Fig. 4). All analyses were related to the expres-
sion of a ubiquitously expressed gene, i.e., b-actin.
Expression of the ABCD-1 mRNA was below levels of
detections (i.e., undetectable after amplification of 50 ng of
cDNA) in brain, liver, kidney (all from RAG-22/2 ani-
mals), and in total unstimulated bone marrow (Fig. 3). It
was also undetectable in purified B lineage precursors of
bone marrow as well as in immature or mature surface
(s)IgM1 B cells from the bone marrow (Fig. 4 A). Trans-
formed cell lines of comparable states of differentiation, i.e.,
the pro B cell–like 63-12 line, the pre B-I cell–like 38B9
line, the pre B-II cell–like NFS-5 and 70Z/3 lines, and the
mature B cell–like A20 line, also did not express ABCD-1.
By contrast, the B cell line WEHI-231 as well as the my-
eloma cell line J558 did express low but detectable levels. A
series of transformed T cell lines (EL-4 and BW5147) and
the IL-2–reactive cytotoxic T cell line CTLL, as well as
NIH-3T3 fibroblasts, the ST-2 stromal cell line, and the
hybridomas Sp2/0 and X63, did not express the ABCD-1
mRNA in detectable amounts. Con A–activated and IL-2–
restimulated splenic T lymphocytes, IL-2–activated NK
cells, and IL-3–induced macrophages also did not express
detectable amounts of ABCD-1 message (Fig. 4 A).
Relatively small amounts of ABCD-1 mRNA were de-
tectable in lung (from RAG-2–deficient mice), unstimu-
lated spleen cells, LN cells, and thymocytes (Fig. 3).
As expected, high levels of ABCD-1 mRNA were de-
tected in R2BFL cells stimulated with anti-CD40 plus IL-4
for either 3 or 6 d in culture (Fig. 4 A). Other pre B-I cell
lines stimulated for 3–6 d with anti-CD40 plus IL-4 (like
the bcl-2-5.8 line) also showed this high level of chemo-
kine mRNA expression. Since the unstimulated pro B and
pre B-I cell lines growing on stromal cells in the presence
of IL-7 or differentiating in the absence of IL-7, or upon
stimulation with either IL-4 or anti-CD40 alone in the ab-
sence of IL-7, did not express ABCD-1 mRNA, expres-
sion appears to be induced by the removal of IL-7 and the
addition of anti-CD40 plus IL-4 to the cultured cells.
ABCD-1 mRNA expression was also inducible by anti-
CD40 plus IL-4, as well as anti-CD40 alone, in B2201
spleen cells (containing in majority mature B cells) and in
the transformed B cell lines A20 and WEHI-231 within 2 d
of anti-CD40 stimulation (Fig. 4). These results indicate
that activated B cells are major producers of the chemokine.
Splenic mature B cells, purified by FACSÒ, could be ac-
tivated not only in the CD40-dependent way (i.e., T cell–
dependent) but also in other polyclonal ways, i.e., by LPS
or by Ig-specific mAbs (i.e., T cell–independent) to high
levels of ABCD-1 mRNA expression (Fig. 4 B).
One other likely source for production of ABCD-1 is
DC. Freshly sorted, unstimulated CD11c1 mesenteric LN
DC expressed similar amounts of chemokine mRNA as did
anti-CD40–activated splenic B cells (Fig. 4 B). Stimulation
of CD11c1 mesenteric LN DC with either anti-CD40 or
GM-CSF plus TNF-a for 24 h did not change mRNA
levels of the chemokine.
Differential Expression of the ABCD-1, RANTES, MIP-
1a, and MCP-1 Chemokines. mRNA from R2BFL cells
stimulated with anti-CD40 plus IL-4, spleen cells stimu-
lated with anti-CD40 or Con A, freshly isolated cells from
bone marrow and thymus, and RAG-2–deficient bone
marrow cells cultured in the presence of rIL-3 (primarily
Figure 3. ABCD-1 expression in mouse tissues. (A) Northern blot
analyses of ABCD-1 mRNA expression. Approximately 30 mg of total
RNA from the indicated cell sources was electrophoresed in a 1.2% aga-
rose formaldehyde gel. After transfer, the filter was hybridized first to a
ABCD-1–specific probe and subsequently to a b-actin probe. Because of
the very strong signal in RNA from induced R2BFL cells, z4 mg of total
RNA was loaded in these lanes. (B) Semiquantitative RT-PCR of
ABCD-1 mRNA levels. The same RNA samples as in A were reverse
transcribed, and serial 1:5 dilutions of the cDNA samples were used as
PCR template to amplify ABCD-1 and b-actin. The latter amplification
was used for normalization of the results, which are given as relative units
of ABCD-1 compared with b-actin mRNA expression levels.457 Schaniel et al.
macrophages) were analyzed by semiquantitative RT-PCR
for the presence of ABCD-1, RANTES, MIP-1a, and
MCP-1 mRNA. This analysis demonstrated that anti-
CD40–stimulated R2BFL cells produced primarily ABCD-1
mRNA but not the other chemokines. Similarly, spleen
cells activated by anti-CD40 produced primarily ABCD-1
and very small amounts of MIP-1a. Con A–activated
spleen cells produced ABCD-1 mRNA, but only z20% of
the amount produced by anti-CD40 stimulation, and small
amounts of RANTES and MIP-1a. The ABCD-1 produc-
tion observed is probably an indirect effect, in the sense
that the activated T cells stimulate the B cells which, in
turn, produce ABCD-1 (60). RANTES was produced pri-
marily by thymocytes, and MCP-1 by the macrophage
preparation (data not shown). These results indicate that
anti-CD40 signaling rather selectively upregulates ABCD-1
expression.
Production of Recombinant ABCD-1 in Insect Cells. The se-
quences encompassing the open reading frame were used to
produce the putative chemokine in SL-3 insect cells (49) as
described in Materials and Methods. Recombinant ABCD-1
was purified from pRmHa-3/ABCD-1–transfected SL-3
cell culture supernatants by HighTrap Heparin FPLC, or,
alternatively, an mAb raised against a chemically synthe-
sized polypeptide (amino acids 25–92) was used as an affin-
ity reagent fixed on beads to purify the chemokine, and gel
fractionation. NH2-terminal sequencing of the band mi-
grating at the expected molecular weight resulted in the
sequence GPYGANVEDS, and thus confirmed the com-
puter-predicted NH2 terminus of the mature, 68 amino
acid–long, 7.8-kD chemokine.
The Target Cells for the Biological Activity of ABCD-1.
We used a microchamber migration assay to study the
chemotactic properties of purified recombinant ABCD-1
on different cell populations. No significant increase in the
migratory activity was observed with primary spleen cells,
thymocytes, LN cells, or bone marrow cells exposed to
ABCD-1 at concentrations ranging from 1 ng/ml to 10
mg/ml (Fig. 5 A). Although LPS-activated splenic B cells,
which we showed to produce ABCD-1 mRNA, were not
chemoattracted by ABCD-1 (data not shown), Con A–acti-
vated IL-2–restimulated splenic T lymphoblasts were (Fig.
5, A and B). Migration was concentration dependent, but
inhibited at high doses. FACSÒ analysis of chemoattracted
T cell blasts showed that CD41 and CD81 T lymphoblasts
were attracted equally (data not shown). IL-2–activated
NK1.11, IL-2Ra2, IL-2Rb1 NK cells from RAG-22/2
mice did not show any significant migratory response to
doses up to 10 mg/ml (Fig. 5 B). ABCD-1–containing cul-
ture supernatants from either cDNA-transfected insect cells
or R2BFL cells stimulated with anti-CD40 plus IL-4 were
also able to induce migration of activated T lymphoblasts
(Fig. 5 C).
ABCD-1 Is Most Likely the Murine Orthologue of the Human
Chemokine MDC/STCP-1. During the progress of our
studies, a structurally and functionally similar chemokine was
reported in two independent studies, named macrophage-
derived chemokine (MDC [61]) and stimulated T cell
Figure 4. Semiquantitative RT-PCR analyses of ABCD-1 mRNA ex-
pression (A) in different cell populations and (B) in sorted splenic B cells
(B2201) and purified mesenteric LN DC (CD11c1), cultured in vitro in
the presence of the indicated stimuli for 2 d or 24 h, respectively. Total
RNA was isolated and reverse transcribed. Serial 1:5 dilutions of cDNA
prepared from the indicated cells were used as template to PCR-amplify
ABCD-1 and b-actin sequences. The latter amplification was used for
normalization of the results. The amount of ABCD-1 relative to b-actin
mRNA is shown. BM, Bone marrow. d, Day. M, Marker.458 B and Dendritic Cells Produce T Cell–directed CC Chemokine
chemotactic protein 1 (STCP-1 [62]), respectively. ABCD-1
and MDC/STCP-1 share 64% identity and 83% similarity at
the amino acid level (Fig. 6 A). The human chemokine is
composed of 93 amino acids, but the mouse chemokine
contains 92 amino acids, the last Q93 residue being absent.
The high amino acid sequence homology between
MDC and ABCD-1 prompted us to investigate whether
these chemokines represent murine and human ortho-
logues. Neither of the human studies had investigated the
expression of MDC/STCP-1 by activated B cells. Hence,
we have stimulated B cells from human tonsils with anti-
CD40 plus IL-4 and found them to produce high levels of
MDC/STCP-1–specific mRNA (Fig. 6 B), indicating that
MDC/STCP-1 and ABCD-1 are expressed in the same
type of human and mouse cells. Moreover, we synthesized
cDNA from human or mouse B cells activated with anti-
Figure 5. Chemotaxis of differ-
ent cell populations induced by
ABCD-1. (A) Migratory respon-
siveness to ABCD-1 of freshly
isolated cells from spleen (dia-
monds), LN (ellipses), bone marrow
(triangles), and thymus (windows),
as well as Con A–activated/IL-
2–restimulated T lymphocytes
(rectangles). A single experiment is
shown. (B) ABCD-1 induced mi-
gration of Con A–activated/IL-
2–restimulated T lymphocytes
(ellipses) and in vitro–generated
NK1.11, IL-2Ra2, and IL-2Rb1
NK cells (rectangles) derived by
culture of RAG-2–deficient bone
marrow cells in the presence of
IL-2. The migratory response of
IL-2–induced NK cells was con-
sidered as nonsignificant. The
mean of three to eight individ-
ual experiments is shown. (C)
Chemotaxis of Con A–activated/
IL-2–restimulated T lymphocytes
induced by supernatant of induced
ABCD-1–transfected Schneider cells, diluted 1:50 (lane 1); supernatant of induced mock-transfected Schneider cells, diluted 1:50 (lane 2); medium (lane 3);
supernatant of R2BFL induced with anti-CD40 plus IL-4 for 6 d, diluted 1:100 (lane 4) and 1:1 (lane 5). Concentration of purified recombinant ABCD-1 was
determined by spectrometer measurements at a wavelength of 280 nm. OD280 of 1 was set equal to a protein concentration of 1 mg/ml.
Figure 6. ABCD-1 is the most likely orthologue of
MDC/STCP-1. (A) Alignment of amino acid
sequences of mouse ABCD-1 and human MDC/
STCP-1 chemokines (references 61 and 62). Vertical
lines, Identities; semicolons, similarities. The overall
identity is 64.8%, and the similarity 82.4%. (B) Semi-
quantitative RT-PCR of MDC/STCP-1 mRNA
expression in anti-CD40 plus IL-4–activated human
tonsil B cells. Total RNA was extracted and reverse
transcribed. MDC/STCP-1 and G3PDH were PCR
amplified using serial 1:5 dilutions of cDNA as template. M, Marker. (C) 300 ng of cDNA prepared using the CAP-finder system (see Materials and Methods)
from anti-CD40 plus IL-4–stimulated human tonsil B cells (lane 1), nonstimulated (lane 2), or 3-d–induced (lane 3) R2BFL cells were separated in 1.2% TAE-
agarose gels. After transfer, replica filters were hybridized at high stringency with the MDC-specific probe or at either high or low stringency with the ABCD-1–
specific probe. At high stringency, each probe recognized sequences of its corresponding species. However, at low stringency, the ABCD-1 probe, in addition to
the ABCD-1 signal in the lane with the activated mouse R2BFL cDNA (lane 3), recognized a human species of identical size as that of MDC (lane 1). (D)
Chemotactic responsiveness to ABCD-1 of human IL-12/anti–IL-4–activated (squares), or IL-4/anti–IL-12–activated (diamonds) CD41 T cells. Migratory re-
sponse to human TARC (PeproTech Ltd., London, UK) of human IL-12/anti–IL-4–activated (circles) or IL-4/anti–IL-12–activated (triangles) CD41 T cells was
used as positive control in this experiment.459 Schaniel et al.
CD40 plus IL-4 using the PCR-based system Cap-finder
(Clontech) and hybridized it with an ABCD-1– or MDC-
specific probe, respectively, at high stringency. Under these
conditions, the ABCD-1 probe recognized a species of
cDNAs of z2.2 kb in the mouse cDNA, whereas the
MDC probe recognized a species of cDNA of z2.9 kb in
the human cDNA (Fig. 6 C). No cross-reaction between
the species was observed. However, when the ABCD-1
probe was used under low stringency conditions, it recog-
nized the ABCD-1–specific sequences in the mouse cDNA
and, in addition, recognized a species of cDNAs in the hu-
man sample that comigrated with the signal detected using
the MDC probe. This indicates that the species of human
cDNAs with the closest homology to ABCD-1 are comi-
grating with those detected by the MDC/STCP-1 probe, a
finding consistent with the notion that ABCD-1 is the mu-
rine orthologue of MDC/STCP-1.
The chemotactic activity of recombinant ABCD-1 is not
restricted to activated mouse T cells, since ABCD-1 was
also found to be a potent chemoattractant for human
CD41 T cells stimulated by anti-CD3/anti-CD28 and ei-
ther IL-12 and anti–IL-4 or IL-4 and anti–IL-12 (Fig. 6 D).
IL-4/anti–IL-12–stimulated T cells migrated optimally at
lower concentrations of chemokine than did IL-12/anti–
IL-4–stimulated cells.
All of the above findings are consistent with the notion
that ABCD-1 is the most likely murine orthologue of
MDC/STCP-1.
Discussion
We have generated a sublibrary of cDNA clones that ap-
pears to be highly enriched for sequences which are specif-
ically upregulated when IL-7–dependent pro/pre B-I cells
are induced by the removal of IL-7 and the addition of
CD40-specific mAb and IL-4 to differentiate to B cells
with a mature phenotype and Sm-Se–switched genotype
(14). Because of the very broad developmental changes that
occur during such a stimulation, a very heterogeneous
group of genes are expected to be found in the subtracted
sublibrary. Genes involved in the changes from pro/pre B-I
to mature B cell, genes induced by either the anti-CD40 or
the IL-4 signal transduction pathways, genes controlling Ig
V-gene hypermutation, and genes involved in Sm-Se
switching are likely candidates. Indeed, several genes al-
ready known to be upregulated when pro/pre B cells de-
velop to mature B cells were found among the selected
clones. They are genes critical for the capacity of develop-
ing B cells to present antigen, namely those encoding
MHC class II proteins (52), the invariant chain of MHC
class II (51), and the MHC locus–linked H-2M gene (53);
genes related to IL-4 signaling, such as the IL-4 receptor
(56); and, finally, genes related to the anti-CD40 plus IL-4
class-switching process, such as the Ig1 and Ie germline
transcripts (for a review, see reference 54). In fact, their fre-
quency within the total collection was one in six cDNA se-
quences in the sublibrary.
One sequence of the remaining clones of the library—
and the structure of the corresponding gene—is described
in this paper. It was present in surprisingly high frequency
among the enriched clones (10 of 120). It was found to en-
code a novel murine member of the CC or b chemokine
family, which we name ABCD-1. We show that this gene
is expressed rather selectively by DC and activated B cells,
but not by resting B cells, T cells, IL-3–induced macro-
phages, or IL-2–stimulated NK cells.
While our characterization of the ABCD-1 gene and its
protein was in progress, two groups independently de-
scribed a human chemokine molecule that is structurally
and functionally related to ABCD-1 (MDC [61] and
STCP-1 [62]). The overall amino acid sequence identity
between the mouse ABCD-1 and the human protein
MDC/STCP-1 is z64% (similarity 84%). In addition, the
genomic organization of the ABCD-1 and STCP-1 genes
is very similar; particularly striking is the identity of se-
quences at the intron–exon boundaries of the mouse and
human gene (Fig. 2 B). All of these findings are strong sup-
port for the notion that the mouse ABCD-1 gene is the
orthologue of the human MDC/STCP-1 gene.
A number of characteristics are the same, or comparable,
for the mouse ABCD-1 and human MDC/STCP-1 chemo-
kines (references 61 and 62, and this report). All three stud-
ies reported that they are expressed at low levels in freshly
isolated cells from thymus, LNs, spleen, and lung. In our
studies, high levels of ABCD-1 mRNA expression were
only seen in DC and activated B lymphocytes, and we have
shown that MDC/STCP-1 is expressed by activated hu-
man B cells. Hence, the patterns of expression are consis-
tent in mouse and human cells. Further evidence for the
close relationship between mouse ABCD-1 and human
MDC comes from hybridization experiments with mouse
and human probes under low or high stringency, suggest-
ing that in human anti-CD40 plus IL-4–stimulated B cells,
the sequences most similar to mouse ABCD-1 are those
encoded by MDC/STCP-1 (Fig. 6 D).
Finally, the chemotactic properties are similar. Activated
mouse T cells of the CD81 as well as CD41 phenotype are
the best chemoattracted cell populations. Activated human
T cells are also chemoattracted by the mouse chemokine
(Fig. 6 D). It is generally accepted that stimulation of anti-
CD3/anti-CD28–activated CD41 human T cells by IL-12
plus anti–IL-4 generates Th1-like cells, whereas stimulation
with IL-4 plus anti–IL-12 develops Th2-like cells. Our re-
sults show that the murine chemokine ABCD-1 acts on
both types of Th cells. These results suggest a close rela-
tionship between the mouse and the human chemokine. Its
role appears to be to attract activated T cells to DC and ac-
tivated B cells, but not to polarize them or select helper or
killer T cell subpopulations.
Other than a low level production of the MIP-1a and
-3a chemokines in some malignant B cell lines (63, 64),
expression of chemokines by normal B cells has not previ-
ously been described. Our discovery that ABCD-1 and
MDC/STCP-1 are produced by mouse and human acti-
vated B cells, respectively, provides a missing link in a sce-
nario that attempts to describe the T cell–dependent activa-460 B and Dendritic Cells Produce T Cell–directed CC Chemokine
tion of B cells and the formation of germinal centers. In
such a scenario, foreign antigen is first taken up and pro-
cessed by immature DC, e.g., Langerhans cells in the epi-
dermis. Inflammatory stimuli lead to activation and differ-
entiation of these immature DC to mature professional
antigen-presenting DC (65), which migrate into the spleen
and into regional LNs. Antigen-presenting mature DC
could do three things. First, they could attract naive T cells
by the production of the DC-CK-1 chemokine (25). Sec-
ond, they could present antigen in the context of MHC
molecules and thus activate the T cells. Third, the produc-
tion of ABCD-1 by the DC would then keep the T cells
attracted to the DC and continuously activated. This is all
likely to occur in or near the T cell–rich regions, e.g., in or
near the periarteriolar lymphocyte sheath of the spleen. As
a result, a focus of antigen-activated T cells could be
formed around the ABCD-1–producing antigen-present-
ing DC.
B cells in B cell–rich follicular regions also have to be ac-
tivated. Our studies show that T cell–independent as well
as T cell–dependent stimulation activates B cells to ABCD-1
production. Once activated, B cells become attractive for
Th cells, which migrate from the periarteriolar lymphocyte
sheath into the follicular areas of the spleen and begin to
interact with activated B cells.
At the same time, the B cells are attracted into the follic-
ular regions by the CXC chemokine BLC (23), alterna-
tively known as BCA-1 (24), which is most likely pro-
duced by FDC. Thereafter, Th cells follow the activated B
cells through chemoattraction via ABCD-1 into the folli-
cle, where T and B cells begin with the formation of a ger-
minal center, i.e., with extensive proliferation, Ig V-region
hypermutation, class switching, and antibody secretion.
Such a scenario makes a number of predictions. First, all
attracted cells should express chemokine-specific receptors.
Hence, activated but not necessarily resting T cells are ex-
pected to express ABCD-1 receptors. In humans, MDC
and TARC bind to CCR4 and attract cells transfected with
CCR4 (66, 67). On the other side, CCR4 is expressed se-
lectively on Th2 cells (68, 69). However, we show that
Th1 and Th2 cells are attracted by ABCD-1. Hence,
ABCD-1 is suspected to have a second receptor expressed
on Th1 cells, and perhaps also on Th2 cells. Future desensi-
tization experiments with the CCR4-specific TARC and
MDC/STCP-1 chemokines (61, 62, 70) and with ABCD-1
might clarify how many chemokine receptors function
with the different chemokines on the different T cells.
The second prediction is that targeted disruption of the
ABCD-1 gene might impede the initiation of T cell–
dependent B cell stimulation and the formation of germinal
centers, like the targeted disruption of BLR-1, the BLC/
BCA receptor (16). The targeted disruption of the ABCD-1
gene is under way.
An exciting new development came from the discovery
that certain chemokines can function as HIV-suppressive
factors. RANTES, MIP-1a, and MIP-1b were shown to
be potent inhibitors of viral infection by monocyte/mac-
rophage-tropic HIV strains (71). Interestingly, Pal and co-
workers (72) have recently identified an HIV-inhibitory
activity in the supernatants of some immortalized CD81
cell lines. When this activity was purified and the protein
sequence was determined, the molecule was identical to
the MDC/STCP-1 chemokine. Hence, we would expect
that ABCD-1, which we show here to chemoattract hu-
man T cells, might also act as an HIV-suppressive factor.
Such experiments are now in progress. Because of this sug-
gested suppressive effect of a B cell–produced chemokine,
administration to HIV-infected individuals of soluble CD40
ligand or anti-CD40 mAb could be an additional way of
inhibiting viral spread.
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